ArticleHuman vaccines & immunotherapeutics2026
Assessing the willingness and preference of pregnant and postpartum women regarding RSV immunization for newborns in western China: A mixed-methods study.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory syncytial virus (RSV) is a leading cause of pediatric lower respiratory tract infections, yet evidence on vaccine acceptance among Chinese pregnant and postpartum women remains limited. This study examines the willingness, preference and factors influencing neonatal RSV immunization among this population in Lanzhou City, China. The study used a convergent mixed-methods approach, including cross-sectional questionnaires and in-depth interviews, and data were processed through multiple regression analysis and thematic analysis. The results showed that the respondents' knowledge of RSV was generally low, with 56.5% indicating that they had never heard of the virus, and only 40.1% expressing willingness to be vaccinated, with most of them preferring monoclonal antibody after the birth of infants to maternal vaccination during pregnancy. The key factors influencing immunization willingness included education level, occupation, experience of vaccine side effects, health status during pregnancy, previous vaccination history during pregnancy, and RSV knowledge level, while the factors influencing immunization preference included annual per capita household income, RSV understanding level and RSV knowledge level. Qualitative interviews further revealed participants' general concerns about the safety and efficacy of vaccination during pregnancy, with national immunization policy and vaccine cost also being important influencing factors. Pregnant and postpartum women demonstrated limited RSV awareness and generally low willingness for immunization, with a clear preference for infant monoclonal antibody administration over maternal vaccination. Comprehensive interventions in terms of health education, service accessibility, financial subsidies and precise communication are recommended to increase immunization rates and reduce the burden of RSV-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.